BME:ECRChemicals
Ercros (BME:ECR) Q1 Losses Deepen And Reinforce Bearish Earnings Narratives
Ercros (BME:ECR) opened 2026 with Q1 revenue of €154.3 million and a basic EPS loss of €0.15, as net income excluding extra items came in at a loss of €13.6 million. The company has seen quarterly revenue move between €136.5 million and €178.6 million since early 2025, while basic EPS losses over the reported periods have ranged from €0.04 to €0.19. This gives investors a clear view of pressure on the income statement even as the top line holds in the mid hundreds of millions. With the stock...